Rational Use and Pharmaceutical Care of Warfarin in Patients with Atrial Fibrillation After PCI

Zhang Huili, Zhong Ning, Yang Qingrui, Ma Lin

Chinese Pharmaceutical Affairs ›› 2020, Vol. 34 ›› Issue (10) : 1225-1230.

Chinese Pharmaceutical Affairs ›› 2020, Vol. 34 ›› Issue (10) : 1225-1230. DOI: 10.16153/j.1002-7777.2020.10.016

Rational Use and Pharmaceutical Care of Warfarin in Patients with Atrial Fibrillation After PCI

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2020, 34(10): 1225-1230 https://doi.org/10.16153/j.1002-7777.2020.10.016

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}

Accesses

Citation

Detail
Sections
Recommended
京ICP备17052540号-7
Copyright © Chinese Pharmaceutical Affairs, All Rights Reserved.
Powered by Beijing Magtech Co. Ltd.

/

〈 〉